These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30118342)

  • 1. MMP-2: is too low as bad as too high in the cardiovascular system?
    Hardy E; Hardy-Sosa A; Fernandez-Patron C
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1332-H1340. PubMed ID: 30118342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
    Yabluchanskiy A; Ma Y; Iyer RP; Hall ME; Lindsey ML
    Physiology (Bethesda); 2013 Nov; 28(6):391-403. PubMed ID: 24186934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Novel Heart-Liver Axis: Matrix Metalloproteinase-2 Negatively Regulates Cardiac Secreted Phospholipase A2 to Modulate Lipid Metabolism and Inflammation in the Liver.
    Hernandez-Anzaldo S; Berry E; Brglez V; Leung D; Yun TJ; Lee JS; Filep JG; Kassiri Z; Cheong C; Lambeau G; Lehner R; Fernandez-Patron C
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26567374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients.
    Fernandez-Patron C; Kassiri Z; Leung D
    Compr Physiol; 2016 Sep; 6(4):1935-1949. PubMed ID: 27783864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis: Metalloproteinase Inhibitors Decrease Risks of Cardiovascular Disease.
    Lizotte-Waniewski M; Brew K; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):368-71. PubMed ID: 26703451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
    Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
    J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate inflammation and fever.
    Berry E; Hernandez-Anzaldo S; Ghomashchi F; Lehner R; Murakami M; Gelb MH; Kassiri Z; Wang X; Fernandez-Patron C
    J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25820137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease.
    Berry E; Bosonea AM; Wang X; Fernandez-Patron C
    J Vasc Res; 2013; 50(1):52-68. PubMed ID: 23172306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Role for Matrix Metalloproteinase 9 in Modulation of Cholesterol Metabolism.
    Hernandez-Anzaldo S; Brglez V; Hemmeryckx B; Leung D; Filep JG; Vance JE; Vance DE; Kassiri Z; Lijnen RH; Lambeau G; Fernandez-Patron C
    J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27694328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
    Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
    Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting MMP-2 to treat ischemic heart injury.
    Hughes BG; Schulz R
    Basic Res Cardiol; 2014 Jul; 109(4):424. PubMed ID: 24986221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial matrix metalloproteinase-2: inside out and upside down.
    DeCoux A; Lindsey ML; Villarreal F; Garcia RA; Schulz R
    J Mol Cell Cardiol; 2014 Dec; 77():64-72. PubMed ID: 25261607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologies of matrix metalloproteinase-2 underactivity: a perspective on a neglected condition
    Cook R; Sarker H; Fernandez-Patron C
    Can J Physiol Pharmacol; 2019 Jun; 97(6):486-492. PubMed ID: 30457883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-2 mediates a mechanism of metabolic cardioprotection consisting of negative regulation of the sterol regulatory element-binding protein-2/3-hydroxy-3-methylglutaryl-CoA reductase pathway in the heart.
    Wang X; Berry E; Hernandez-Anzaldo S; Takawale A; Kassiri Z; Fernandez-Patron C
    Hypertension; 2015 Apr; 65(4):882-8. PubMed ID: 25646300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells prevent angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E knockout mice.
    Meng X; Yang J; Zhang K; An G; Kong J; Jiang F; Zhang Y; Zhang C
    Hypertension; 2014 Oct; 64(4):875-82. PubMed ID: 25024283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases: a therapeutic target in cardiovascular disease.
    Sierevogel MJ; Pasterkamp G; de Kleijn DP; Strauss BH
    Curr Pharm Des; 2003; 9(13):1033-40. PubMed ID: 12678855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.
    Chan BYH; Roczkowsky A; Cho WJ; Poirier M; Lee TYT; Mahmud Z; Schulz R
    Basic Res Cardiol; 2019 Sep; 114(6):42. PubMed ID: 31506724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-2 and -9 expression increases in Mycoplasma-infected airways but is not required for microvascular remodeling.
    Baluk P; Raymond WW; Ator E; Coussens LM; McDonald DM; Caughey GH
    Am J Physiol Lung Cell Mol Physiol; 2004 Aug; 287(2):L307-17. PubMed ID: 15075248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.